Clinical Research Directory
Browse clinical research sites, groups, and studies.
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
Sponsor: Stanford University
Summary
The purpose of this study is to understand how ketamine works in the brain to bring about a reduction in OCD symptoms.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2024-02-24
Completion Date
2028-11
Last Updated
2024-12-19
Healthy Volunteers
Yes
Conditions
Interventions
Ketamine
Ketamine is an FDA-approved dissociative anesthetic.
Naltrexone Pill
Naltrexone is an oral opioid antagonist approved by the Food and Drug Administration (FDA) to treat both alcohol use disorder (AUD) and opioid use disorder (OUD)
Placebo pill
An oral inactive placebo pill will be administered to preserve the blinded nature of the study.
Locations (1)
Department of Psychiatry & Behavioral Sciences
Stanford, California, United States